| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/13/2003 | WO2002038793A9 Hepatitis c virus constructs characterized by high efficiency replication |
| 02/13/2003 | WO2002038765A9 Dna encoding bovine immunoglobulin a inducing protein and uses therefor |
| 02/13/2003 | WO2002033114A3 Protein-protein interactions in neurodegenerative diseases |
| 02/13/2003 | WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | WO2002029105A9 INHIBITION OF TGF-β AND USES THEREOF |
| 02/13/2003 | WO2002026789A3 Nucleotide sequences mediating male fertility and method of using same |
| 02/13/2003 | WO2002026778A3 Isolated peptides which bind to hla-c molecules and uses thereof |
| 02/13/2003 | WO2002020752A3 Cloned cells, embryos, and avians and methods, of producing them |
| 02/13/2003 | WO2002006534A3 Method of diagnosing pulmonary hypertension |
| 02/13/2003 | WO2002003793A3 Transgenic mice containing targeted gene disruptions |
| 02/13/2003 | WO2001092567A3 Novel target genes for diseases of the heart |
| 02/13/2003 | WO2001092331A8 Compositions and methods for the treatment of immune related diseases |
| 02/13/2003 | WO2001085763A3 Chimeric peptide immunogens their preparation and use |
| 02/13/2003 | WO2001067855A3 Transgenic mice containing targeted gene disruptions |
| 02/13/2003 | WO2001057277A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver |
| 02/13/2003 | WO2001057270A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and hbl 100 cells |
| 02/13/2003 | US20030033637 Generation of transforming growth factor protein in plants; obtain plant, transform with vector containing transforming growth factor, culture and propagate plant, recover protein |
| 02/13/2003 | US20030033636 Expression of eukaryotic peptides in plant plastids |
| 02/13/2003 | US20030033629 RecA proteins |
| 02/13/2003 | US20030033628 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants |
| 02/13/2003 | US20030033625 Transgenic mice containing CLCN4 chloride ion channel gene disruptions |
| 02/13/2003 | US20030033624 Expression vector for use as nucleotide sequences transfer tool in gene therapy |
| 02/13/2003 | US20030033623 Animal model for use in the treatment and diagnosis of nervous system disorders |
| 02/13/2003 | US20030033621 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease |
| 02/13/2003 | US20030033620 Animal model for parkinson's disease and method of making same |
| 02/13/2003 | US20030033618 Generation of mammalian protein in trangenic animal; obtain embryo, transform with expression vector, propagate embryo to maturity, induce lactation, recover milk, isolate membran protein |
| 02/13/2003 | US20030033615 Animal model for use in the evaluation of carcinogenicity or toxigenicity of a drug or therapeutic compound |
| 02/13/2003 | US20030033614 Method for identifying hormonally modulated genes |
| 02/13/2003 | US20030032793 Gene of PGT of human brain type |
| 02/13/2003 | US20030032792 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of gastrointestinal, crohn's, inflammatory bowel, diabetes and cancer, |
| 02/13/2003 | US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders |
| 02/13/2003 | US20030032790 Mammal use as model in the diagnosis, prevention and treatment of hypercholesteremia or hyperlipoproteinemia, obesity, diabetes, tumors, anorexia, hyperlipidemia, lipoprotein defects, osteoporosis, arthritis and tumors |
| 02/13/2003 | US20030032787 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malarial infection |
| 02/13/2003 | US20030032786 Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM2 |
| 02/13/2003 | US20030032785 Detection of ligand and ligand sequences in sample; obtain nucleotide sequence samples, partitioning sample, incubate with primers, propagate and amplify sequences |
| 02/13/2003 | US20030032784 Novel G protein-coupled receptors |
| 02/13/2003 | US20030032783 Nucleotide sequences coding polypeptide for use in the treatment of hyperlipidemia, diabetes, brain, arteriosclerosis, and cardiovascular disorders |
| 02/13/2003 | US20030032781 Antibody for use in the treatment of cancer |
| 02/13/2003 | US20030032780 Process for inactivating pionts in lipoproteins |
| 02/13/2003 | US20030032779 Estrogen receptor ligands |
| 02/13/2003 | US20030032778 New member of the human syntaxin/epimorphin family |
| 02/13/2003 | US20030032777 Precursor polypeptide of phytosulfokine derived from Arabidopsis thaliana and a gene encoding said polypeptide |
| 02/13/2003 | US20030032776 Polynucleotide encoding a novel human potassium channel beta-subunit, K+Mbeta1 |
| 02/13/2003 | US20030032775 Effector proteins of rapamycin |
| 02/13/2003 | US20030032773 Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression |
| 02/13/2003 | US20030032772 Peptide for use in the diagnosis and prevention of immunological and infectious disorders |
| 02/13/2003 | US20030032771 Peptide inhibitors of cellular proliferation |
| 02/13/2003 | US20030032769 Second mammalian tankyrase |
| 02/13/2003 | US20030032615 Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response |
| 02/13/2003 | US20030032609 Promoting agniogenesis with a compound that increases expression of VEGF; inhibiting angiogenesis with a compound that inhibits binding of endothelial PAS domain protein-1 to cis-acting transcription regulatory DNA an angiogenic factor. |
| 02/13/2003 | US20030032608 Polynucleotides encoding a novel glycine receptor alpha subunit expressed in the gastrointestinal tract, HGRA4, and splice variant thereof |
| 02/13/2003 | US20030032606 Methods of detecting and treating microsatellite-instability positive tumors using RIZ |
| 02/13/2003 | US20030032593 Transporters comprising spaced arginine moieties |
| 02/13/2003 | US20030032592 Protein-protein interactions |
| 02/13/2003 | US20030032591 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 02/13/2003 | US20030032588 Glucagon antagonists |
| 02/13/2003 | US20030032587 Urocortin peptides |
| 02/13/2003 | US20030032585 The use of trefoil factor 2 (TFF2) peptides increasing the viscosity of mucus layers in mammals |
| 02/13/2003 | US20030032582 Spontaneous membrane insertion |
| 02/13/2003 | US20030032200 Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression |
| 02/13/2003 | US20030032168 Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein |
| 02/13/2003 | US20030032167 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 02/13/2003 | US20030032166 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 02/13/2003 | US20030032160 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis |
| 02/13/2003 | US20030032159 Human ralgds-like protein 3 |
| 02/13/2003 | US20030032158 Method of modulating the efficiency of translation termination and degradation of aberrant mRNA involving a surveillance complex comprising human Upf1p,eucaryotic release factor 1 and eucaryotic release factor 3 |
| 02/13/2003 | US20030032157 Polypeptide for use in the treatment of cancer |
| 02/13/2003 | US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 02/13/2003 | US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032154 Human LCCL domain containing protein |
| 02/13/2003 | US20030032152 Genetically engineered yeast for use in the generation of lactic acid |
| 02/13/2003 | US20030032146 Enzyme/tag binding and detection system |
| 02/13/2003 | US20030032145 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altered pharmacological properties |
| 02/13/2003 | US20030032144 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 02/13/2003 | US20030032143 Collagen type I and type III compositions for use as an adhesive and sealant |
| 02/13/2003 | US20030032142 Nucleotide sequences coding membrane protein for use in the treatment and prevention of infections |
| 02/13/2003 | US20030032141 Protein and nucleic acid expression systems |
| 02/13/2003 | US20030032140 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032139 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032138 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032137 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032136 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032135 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032134 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032133 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032132 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032131 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032129 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032128 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032127 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032126 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032125 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032124 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032123 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032122 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032121 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032120 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032119 Secreted and transmembrane polypeptides and nucleic acids encoding the same |